Relay Therapeutics RLAY
NASDAQ RLAY
$19.94 -0.45 (-2.21%)
At close: Nov 10, 2026 · 4:00 PM EST

Relay Therapeutics (RLAY) Share-based Compensation (IS) (2019 - 2020)

Updated

Relay Therapeutics (RLAY) posted Share-based Compensation (IS) of $11.93 million for Q3 2020, up 855.8% from $1.25 million a year earlier and up 195.9% from the prior quarter.

Analysis

Relay Therapeutics (RLAY) Share-based Compensation (IS) (2019 - 2020) Analysis & Trends

For the trailing twelve months through Sep 30, 2020, Share-based Compensation (IS) at Relay Therapeutics was $18.72 million; for FY2019, it was $4.46 million.

  • According to Business Quant data, Share-based Compensation (IS) for the three prior quarters was $4.03 million (Q2 2020), $1.46 million (Q1 2020) and $1.31 million (Q4 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Relay Therapeutics 4.43 Bn 3.90 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 11.93 Mn
Jun 30, 2020 4.03 Mn
Mar 31, 2020 1.46 Mn
Dec 31, 2019 1.31 Mn
Sep 30, 2019 1.25 Mn
Jun 30, 2019 1.09 Mn
API Access

Relay Therapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=RLAY&period=max&api_key=YOUR_API_KEY